Science & Technology
Addressing Emerging Drug Threats with InstaStrip Rapid Tests
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1U44DA060264-01
Award Ceiling
$330K
Award Floor
$330K
Close Date
Apr 30, 2025
Total Funding
$330K
Expected Awards
1
Posted Date
May 1, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1U44DA060264-01
Description
SBIR Phase Phase I award: "Addressing Emerging Drug Threats with InstaStrip Rapid Tests" awarded to Instanosis, Inc. in Milford, Delaware. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $330,137. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.